You are here

Genmab

AbbVie & Genmab EHA Data Indicate LBCL Drug Could Fill Unmet Need

BioSpace

Mon, 06/13/22 - 09:51 pm

clinical trials

AbbVie preps filings for lymphoma bispecific licensed from Genmab

Pharmaforum

Thu, 04/14/22 - 10:39 am

large B-cell lymphoma

J&J scores one-two royalty punch against Genmab in blockbuster Darzalex fight

Fierce Pharma

Fri, 04/8/22 - 10:22 am

Multiple Myeloma

With $415M on the line, Genmab taps Synaffix for antibody-drug conjugate technologies

Fierce Biotech

Tue, 01/4/22 - 10:41 am

antibody-drug conjugate

What Novartis could buy with its windfall

EP Vantage

Fri, 11/5/21 - 09:40 am

Aurinia Pharmaceuticals

FDA hands accelerated nod to Seagen, Genmab's solo ADC in cervical cancer, but combo studies look even more promising

Endpoints

Mon, 09/20/21 - 11:01 pm

accelerated approval

cervical cancer

Straight after its first cancer bispecific OK, J&J highlights two more at ASCO

Pharmaforum

Tue, 05/25/21 - 10:59 am

Multiple Myeloma

Genmab could spin out autoimmune disease unit, says CEO

Pharmaforum

Wed, 04/7/21 - 10:22 am

autoimmune disease

Genmab creates new CMO, head of experimental medicines role for Ahmadi

Fierce Biotech

Mon, 02/22/21 - 10:35 am

Genmab axes an ADC development program after the data fail to impress

Endpoints

Tue, 11/24/20 - 11:18 pm

antibody-drug conjugate

enapotamab vedotin

J&J's Darzalex Proves Effective in Yet Another Multiple Myeloma Indication

BioSpace

Thu, 10/22/20 - 11:01 pm

clinical trials

Multiple Myeloma

J&J’s next-gen Darzalex sparks drug delivery royalties battle

Fierce Pharma

Thu, 09/24/20 - 11:32 pm

Genmab and Janssen Head to Arbitration Table Over Darzalex Royalties

BioSpace

Wed, 09/23/20 - 10:22 am

Multiple Myeloma

Seattle Genetics/Genmab's tisotumab’s cervical cancer efficacy falls off

EP Vantage

Tue, 06/30/20 - 10:34 am

cervical cancer

tisotumab vedotin

Seattle Genetics

clinical trials

AbbVie to pay Genmab $750M upfront to form bispecific R&D pact

Fierce Biotech

Wed, 06/10/20 - 11:01 am

bispecific antibodies

Upcoming events – Genmab's route to market, and late-stage data for Zogenix

EP Vantage

Fri, 01/24/20 - 10:50 am

tisotumab vedotin

cervical cancer

Lennox-Gastaut Syndrome

A Look at 5 Big and Interesting Biotech IPOs for 2019

BioSpace

Fri, 12/20/19 - 12:36 pm

Adaptive Biotechnologies

[video] Genmab IPO raises $582m, becoming second largest US IPO ever by a bio-tech company

Yahoo Finance

Wed, 09/11/19 - 09:51 am

Mark Your Calendar For These September PDUFA Dates

Yahoo/Benzinga

Wed, 08/28/19 - 12:53 pm

Xeris Pharmaceuticals

Denmark's Genmab hits the jackpot with $500M+ US IPO as smaller biotechs rake in a combined $147M

Endpoints

Thu, 07/18/19 - 10:12 am

Pages